List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Hand, Foot and Mouth Disease - Overview
Hand, Foot and Mouth Disease - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Hand, Foot and Mouth Disease - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Hand, Foot and Mouth Disease - Companies Involved in Therapeutics Development
Adimmune Corp
Beijing Minhai Biotechnology Co Ltd
Changchun Bcht Biotechnology Co Ltd
Chongqing Zhifei Biological Products Co Ltd
Emergex Vaccines Ltd
HK inno.N Corp
Sentinext Therapeutics Sdn Bhd
Shanghai Zerun Biotechnology Co Ltd
Hand, Foot and Mouth Disease - Drug Profiles
(coxsackievirus [serotype A16] + enterovirus [serotype 71]) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
B-1108 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CJ-40010 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
D-5 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DC-07090 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
E-71 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
enterovirus [serotype 71] (virus like particle) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Enterovirus [serotype EV-71/C4] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Enterovirus [serotype EV-A71] (virus like particle, bivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Enterovirus [serotype EV-A71] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hand, foot and mouth disease (bivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hand, foot and mouth disease vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclonal Antibody for Hand, Foot and Mouth Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit MAP2K1 for Hand, Foot and Mouth Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
STX-100 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Hand, Foot and Mouth Disease - Dormant Projects
Hand, Foot and Mouth Disease - Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Hand, Foot and Mouth Disease, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Hand, Foot and Mouth Disease - Pipeline by Adimmune Corp, H2 2020
Hand, Foot and Mouth Disease - Pipeline by Beijing Minhai Biotechnology Co Ltd, H2 2020
Hand, Foot and Mouth Disease - Pipeline by Changchun Bcht Biotechnology Co Ltd, H2 2020
Hand, Foot and Mouth Disease - Pipeline by Chongqing Zhifei Biological Products Co Ltd, H2 2020
Hand, Foot and Mouth Disease - Pipeline by Emergex Vaccines Ltd, H2 2020
Hand, Foot and Mouth Disease - Pipeline by HK inno.N Corp, H2 2020
Hand, Foot and Mouth Disease - Pipeline by Sentinext Therapeutics Sdn Bhd, H2 2020
Hand, Foot and Mouth Disease - Pipeline by Shanghai Zerun Biotechnology Co Ltd, H2 2020
Hand, Foot and Mouth Disease - Dormant Projects, H2 2020
Hand, Foot and Mouth Disease - Discontinued Products, H2 2020

List of Figures
Number of Products under Development for Hand, Foot and Mouth Disease, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Targets, H2 2020
Number of Products by Stage and Targets, H2 2020
Number of Products by Mechanism of Actions, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020

Companies Mentioned
• Adimmune Corp
• Beijing Minhai Biotechnology Co Ltd
• Changchun Bcht Biotechnology Co Ltd
• Chongqing Zhifei Biological Products Co Ltd
• Emergex Vaccines Ltd
• HK inno.N Corp
• Sentinext Therapeutics Sdn Bhd
• Shanghai Zerun Biotechnology Co Ltd